Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue

por Hushpulian, Dmitry M., Ammal Kaidery, Navneet, Ahuja, Manuj, Poloznikov, Andrey A., Sharma, Sudarshana M., Gazaryan, Irina G., Thomas, Bobby
Publicado 2021

Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson’s Disease

por Ahuja, Manuj, Kaidery, Navneet Ammal, Dutta, Debashis, Attucks, Otis C., Kazakov, Eliot H., Gazaryan, Irina, Matsumoto, Mitsuyo, Igarashi, Kazuhiko, Sharma, Sudarshana M., Thomas, Bobby
Publicado 2022

Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2

por Popov, Alexander, Klimovich, Anna, Styshova, Olga, Tsybulsky, Alexander, Hushpulian, Dmitry, Osipyants, Andrey, Khristichenko, Anna, Kazakov, Sergey, Ahuja, Manuj, Kaidery, Navneet, Thomas, Bobby, Tishkov, Vladimir, Brown, Abraham, Gazaryan, Irina, Poloznikov, Andrey
Publicado 2022

Bach1 derepression is neuroprotective in a mouse model of Parkinson’s disease

por Ahuja, Manuj, Ammal Kaidery, Navneet, Attucks, Otis C., McDade, Erin, Hushpulian, Dmitry M., Gaisin, Arsen, Gaisina, Irina, Ahn, Young Hoon, Nikulin, Sergey, Poloznikov, Andrey, Gazaryan, Irina, Yamamoto, Masayuki, Matsumoto, Mitsuyo, Igarashi, Kazuhiko, Sharma, Sudarshana M., Thomas, Bobby
Publicado 2021